Santen Pharmaceutical Co., Ltd. (SNPHY)
10.69
-0.13
(-1.20%)
USD |
OTCM |
May 08, 16:00
Santen Pharmaceutical Shareholders Equity (Quarterly) : 1.808B for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 48.76B |
| Daiichi Sankyo Co., Ltd. | 10.91B |
| Eisai Co., Ltd. | 5.676B |
| Chugai Pharmaceutical Co., Ltd. | 11.99B |
| Ono Pharmaceutical Co., Ltd. | 5.357B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.559B |
| Total Liabilities (Quarterly) | 757.43M |
| Debt to Equity Ratio | 0.1276 |
| Current Ratio | 2.684 |
| Net Debt Paydown Yield | -0.06% |